Vumerity

E24937

Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.

AI illustration

How this image was made

AI-generated illustration of Vumerity

This AI-generated illustration was produced by black-forest-labs/FLUX.2-dev (1024x1024) from a prompt written by openai/gpt-oss-120b from the entity's label + description.

Prompt

Generate an image of Vumerity (Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.)

All labels observed (2)

Label Occurrences
diroximel fumarate 2
Vumerity canonical 1

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf multiple sclerosis therapy ⓘ
pharmaceutical drug ⓘ
prescription medication ⓘ
belongsToRegimenType disease-modifying therapy for multiple sclerosis ⓘ
brandOf diroximel fumarate ⓘ
linked to: Vumerity
chemicallyRelatedTo dimethyl fumarate ⓘ
commonAdverseEffect abdominal pain ⓘ
diarrhea ⓘ
flushing ⓘ
nausea ⓘ
contraindicatedIn known hypersensitivity to dimethyl fumarate ⓘ
known hypersensitivity to diroximel fumarate ⓘ
developedBy Alkermes ⓘ
Biogen ⓘ
FDAApprovalYear 2019 ⓘ
foodEffect may be taken with or without food ⓘ
taking with food may reduce flushing ⓘ
hasAdministrationFrequency twice daily ⓘ
hasDosageForm delayed-release capsule ⓘ
hasGenericName diroximel fumarate ⓘ
linked to: Vumerity
hasInitialDoseRegimen lower dose for first 7 days ⓘ
hasMaintenanceDoseRegimen higher dose after first week ⓘ
hasMechanismOfAction fumarate derivative ⓘ
thought to activate the Nrf2 pathway ⓘ
hasPharmacologicClass fumaric acid ester ⓘ
immunomodulator ⓘ
hasPregnancyCategory risk not ruled out ⓘ
hasRegulatoryApproval U.S. Food and Drug Administration ⓘ
hasRouteOfAdministration oral ⓘ
hasRouteWarning do not crush, chew, or sprinkle capsule contents ⓘ
hasTherapeuticGoal reduce MRI lesion activity in multiple sclerosis ⓘ
reduce relapse rate in multiple sclerosis ⓘ
slow disability progression in multiple sclerosis ⓘ
indicatedFor active secondary progressive multiple sclerosis ⓘ
clinically isolated syndrome ⓘ
relapsing forms of multiple sclerosis ⓘ
relapsing-remitting multiple sclerosis ⓘ
indicatedPopulation adults ⓘ
isTakenWith water ⓘ
marketedBy Biogen ⓘ
metabolizedTo monomethyl fumarate ⓘ
requiresMonitoring liver function tests ⓘ
lymphocyte counts ⓘ
seriousAdverseEffect liver injury ⓘ
lymphopenia ⓘ
progressive multifocal leukoencephalopathy ⓘ

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Biogen → hasProduct → Vumerity ⓘ
Vumerity → hasGenericName → diroximel fumarate ⓘ
linked to: Vumerity
Vumerity → brandOf → diroximel fumarate ⓘ
linked to: Vumerity